On track for an FDA decision mid-year
Announced restructuring to extend cash runway
Completed private placement financing
Company to host conference call and webcast today at 8:30 a.m. ET
. | May 11, 2023
vTv Therapeutics Announces 2023 First Quarter Financial Results and Provides Corporate Update HIGH POINT, N.C. - May 11, 2023 - vTv Therapeutics Inc. , a. | May 11, 2023
Core business outperforms, delivering 14% topline growth; Customer acquisition strength in March drives full-year guidance higher; Unlevered free cash flow margin of 28% resulting from pricing. | May 9, 2023
– UDENYCA® autoinjector approved and ready for May 2023 launch –– CIMERLI® product-specific Q-code now facilitating electronic reimbursement following April 1 activation. | May 8, 2023